Brief: Mabion Extends Cooperation With Novavax

Mabion SA

23/11/2022 15:31

Nov 23 (Reuters) - Mabion SA  MABP.WA :
    * EXTENDS COOPERATION WITH NOVAVAX
    * UNDER EXTENSION COMPANY TO ANALYSE PEPTIDE MAPPING FOR
ACTIVE
SUBSTANCE AND FINISHED PRODUCT OF RS SARS-COV-2 PROTEIN SAMPLE
    * FIRST STAGE OF WORK WILL BE IMPLEMENTATION OF PEPTIDE
MAPPING
METHOD
    * REMUNERATION FOR FIRST STAGE OF CONTRACT AT OVER $0.5
MILLION
    * TOTAL VALUE OF STATEMENT OF WORK #9 WILL DEPEND ON NEXT
STAGE OF
ORDER
    * COMPANY TO ALSO CARRY OUT REGULAR ANALYSIS OF CONTRACTED
SAMPLES, RESULTING IN ISSUING APPROPRIATE CERTIFICATE

Source text for Eikon:  ID:nEM3bBdv8a 
Further company coverage:  MABP.WA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))